Diclofenac: Potent Relief for Inflammation and Pain
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.55 | $49.22 (0%) | 🛒 Add to cart |
| 180 | $0.41 | $98.44 $73.33 (26%) | 🛒 Add to cart |
| 270 | $0.37 | $147.66 $99.44 (33%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $196.88 $121.54 (38%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.37 | $67.30 (0%) | 🛒 Add to cart |
| 270 | $0.33 | $100.95 $88.40 (12%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $134.60 $110.49 (18%) | 🛒 Add to cart |
Diclofenac is a widely prescribed nonsteroidal anti-inflammatory drug (NSAID) renowned for its efficacy in managing moderate to severe pain, reducing inflammation, and alleviating fever. As a potent inhibitor of cyclooxygenase (COX) enzymes, it effectively interferes with prostaglandin synthesis, addressing the biochemical pathways responsible for pain and swelling. It is available in multiple formulations—including oral tablets, topical gels, and injectable solutions—to suit varied clinical needs and patient tolerances. Healthcare professionals frequently recommend diclofenac for its rapid onset of action and well-documented therapeutic profile across numerous inflammatory and painful conditions.
Features
- Chemical name: 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid
- Available as sodium or potassium salt for optimized bioavailability
- Multiple formulations: oral (tablet, capsule), topical (gel, patch), injectable, and suppository
- COX-1 and COX-2 enzyme inhibition with preferential activity toward COX-2
- Half-life of approximately 1–2 hours (oral), with sustained-release versions available
- Rapid absorption; peak plasma concentrations reached within 1–3 hours (oral immediate-release)
Benefits
- Provides effective and rapid relief from acute and chronic inflammatory pain
- Reduces swelling, stiffness, and joint tenderness in arthritic conditions
- Helps restore mobility and functional capacity in patients with musculoskeletal disorders
- Offers flexible administration routes to accommodate individual patient needs and contraindications
- Supported by extensive clinical evidence demonstrating safety and efficacy when used appropriately
- May decrease dependency on opioid analgesics for certain types of pain management
Common use
Diclofenac is commonly indicated for the management of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, where inflammation contributes significantly to symptomatology. It is also employed in acute settings for pain relief following surgical or dental procedures, as well as in cases of acute gout flares. Musculoskeletal conditions such as tendinitis, bursitis, and lower back pain often respond favorably to diclofenac therapy. Topical formulations are particularly useful for localized pain, such as in osteoarthritis of superficial joints like the knees or hands, minimizing systemic exposure. Off-label uses may include migraine treatment and postoperative inflammation control, though these should be guided by clinical judgment.
Dosage and direction
Dosage varies by indication, formulation, and patient-specific factors such as renal function and comorbidities. For oral tablets in adults, the typical starting dose for osteoarthritis is 50 mg two to three times daily, or 75 mg twice daily. Rheumatoid arthritis may require 50 mg three to four times daily. Extended-release tablets are dosed once daily at 100 mg. Topical gel (1% or 3%) should be applied four times daily to the affected area, not exceeding a total daily dose as specified per product guidelines. Injectables are generally administered under medical supervision. Always take oral diclofenac with food or milk to minimize gastrointestinal upset. Do not crush or chew extended-release formulations. Adhere strictly to prescribed durations to avoid unnecessary risks.
Precautions
Patients with a history of gastrointestinal bleeding, ulceration, or perforation should use diclofenac with extreme caution. Renal and hepatic function should be assessed periodically during long-term therapy, especially in elderly patients or those with pre-existing conditions. Cardiovascular risk assessment is advised, particularly in patients with hypertension, heart failure, or established cardiovascular disease. Avoid concomitant use of other NSAIDs, including over-the-counter products like aspirin. Use during pregnancy, especially in the third trimester, is contraindicated due to risk of premature closure of the ductus arteriosus. Topical formulations should not be applied to broken or infected skin.
Contraindications
Diclofenac is contraindicated in patients with known hypersensitivity to diclofenac, aspirin, or other NSAIDs. It must not be used in individuals who have experienced asthma, urticaria, or allergic-type reactions after taking NSAIDs. Contraindications also include active peptic ulcer disease, recent gastrointestinal bleeding or perforation, severe heart failure, and severe hepatic impairment. It is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. Use in pregnant women near term should be avoided.
Possible side effect
Common side effects include gastrointestinal symptoms such as dyspepsia, nausea, abdominal pain, and diarrhea. Less frequently, dizziness, headache, and peripheral edema may occur. Serious adverse effects can include gastrointestinal bleeding, ulceration, or perforation; hepatotoxicity (elevated liver enzymes, jaundice); renal impairment; and increased risk of cardiovascular events like myocardial infarction or stroke. Skin reactions, including photosensitivity and rare severe cutaneous adverse reactions (e.g., Stevens-Johnson syndrome), have been reported. Topical formulations may cause local reactions like dryness, itching, or rash at the application site.
Drug interaction
Diclofenac may interact with anticoagulants like warfarin, increasing the risk of bleeding. Concurrent use with other NSAIDs or corticosteroids elevates gastrointestinal toxicity. ACE inhibitors, angiotensin II receptor blockers, and diuretics may see reduced efficacy when co-administered with diclofenac, and renal function should be monitored. Diclofenac can increase lithium and methotrexate levels, necessitating dose adjustments. Cyclosporine and diclofenac co-administration may enhance nephrotoxicity. SSRIs and SNRIs can further increase bleeding risk.
Missed dose
If a dose is missed, take it as soon as remembered, unless it is nearly time for the next scheduled dose. Do not double the dose to catch up. For once-daily formulations, if a dose is skipped, resume the regular schedule the following day. Consistent dosing is important for maintaining therapeutic effect, but occasional missed doses are unlikely to cause significant issues. Patients should not compensate by applying extra topical product.
Overdose
Symptoms of overdose may include nausea, vomiting, epigastric pain, gastrointestinal bleeding, drowsiness, dizziness, tinnitus, or seizures. Hypertension, acute renal failure, respiratory depression, and coma are possible in severe cases. There is no specific antidote; management is supportive and includes gastric lavage or activated charcoal if presented early. Hemodialysis is not effective due to high protein binding. Monitor and treat symptoms aggressively, with particular attention to electrolyte balance, renal function, and gastrointestinal protection.
Storage
Store at room temperature (20–25°C or 68–77°F), away from light, moisture, and heat. Keep oral forms in their original container, tightly closed. Topical gels and patches should be stored upright and kept out of reach of children. Do not freeze. Discard any unused medication after the expiration date or as directed, avoiding flushing or pouring into drains unless instructed.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Individual patient needs and responses may vary. The author and publisher are not liable for any adverse effects resulting from the use or misuse of this information.
Reviews
Clinical studies and meta-analyses consistently affirm diclofenac’s efficacy in pain and inflammation management, with many practitioners noting its reliability and rapid action. Patient-reported outcomes often highlight significant improvement in quality of life and mobility, though gastrointestinal side effects are a recurring concern in long-term users. Topical formulations receive positive feedback for localized efficacy with minimal systemic effects. Overall, diclofenac remains a cornerstone in anti-inflammatory therapy, backed by decades of clinical use and research.